Document is current
Any future updates will be listed below
-
Authors
Kastbom, Lisa https://orcid.org/0000-0002-9860-7593
Lyth, Johan https://orcid.org/0000-0002-4988-6346
Simmons, Johanna https://orcid.org/0000-0003-0704-202X
Martinsson, Lisa https://orcid.org/0000-0003-4126-2675
Eriksdotter, Maria https://orcid.org/0000-0003-2498-4000
Lundström, Staffan https://orcid.org/0000-0002-5699-7757
Nägga, Katarina https://orcid.org/0000-0003-0194-8402
Segernäs, Anna https://orcid.org/0000-0001-8111-7742
-
Funding
Funding for this research was provided by:
Linköping University
- License Information
-
More Information
Article History
Received: 24 October 2025
Accepted: 23 February 2026
First Online: 7 March 2026
Declarations
:
: The study was performed in line with “World Medical Association Declaration of Helsinki: Research involving human subjects”. Advisory approval was granted by the Swedish Ethical Review Authority in Umeå 31 Nov 2021 (Dnr.: 2021-05359-01). They had no ethical objections to the study. Since data collection was conducted after the patients’ death, informed consent could not be obtained and the need for consent was waived by the ethics committee.
: Not applicable.
: The authors, except ME, declare that they have no competing interests. ME has served as a speaker and/or consultant on dementia on sporadic advisory board meetings for Biogen, Bioarctic, Roche, Novonordisk and Eli Lilly.
